Should I use a 5-panel or a 10-panel drug test?
A 5-panel is enough for most private-sector workplace programs. A 10-panel is worth the additional cost when the program needs to monitor prescription depressants — typical in healthcare, recovery monitoring, and safety-sensitive non-DOT contexts. Neither is federally regulated under SAMHSA — the federally regulated panel is the DOT 5-panel.
Side-by-side comparison
| Attribute | 5-panel | 10-panel |
|---|---|---|
| Analytes | THC, cocaine, opiates, amphetamines, PCP | 5-panel + benzodiazepines, barbiturates, methadone, more opioids, fentanyl (in many configurations) |
| Common use | Private-sector workplace screening | Healthcare, recovery monitoring, safety-sensitive non-DOT |
| Cost | $ | $$ |
| Prescription monitoring | No | Yes — benzodiazepines, methadone, opioids |
| MRO review complexity | Lower | Higher — more prescription verification |
| Federal regulation | Not federally regulated; common-practice | Not federally regulated; common-practice (10-panel is not a SAMHSA-defined panel) |
When a 5-panel is enough
- Standard private-sector pre-employment, random, reasonable suspicion, post-accident testing.
- Programs where cost-effectiveness and broad coverage of major drug classes are the priority.
- Where the program is not designed to monitor for prescription compliance.
When the 10-panel earns its keep
- Healthcare settings with controlled-substance access.
- Recovery and treatment programs monitoring for benzodiazepine, methadone, or extended opioid use.
- Safety-sensitive non-DOT roles (utilities, manufacturing, certain transportation outside DOT scope).
- Court-ordered or probation programs that require expanded coverage.
Sources & references
drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.